Anesthesia Drugs: Worldwide Markets

Questions: Discounts, Updates etc.

Pages: 156

Price (Single):

Price (Company):

Publication Date: 2007-07-01

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *


The number of procedures requiring anesthetic administration continues to climb with the growing and aging population in many regions of the world. The population of the world plays an important role in the growing incidence and prevalence of disease and will reflect positively on growth for anesthesia drugs.

This report - Anesthesia Drugs: Worldwide Markets - focuses on three primary segments of anesthesia:

The report covers both currently marketed and late stage development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product.

The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. The market segments provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

The issues and trends addressed in the anesthesia drug market include:

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study

Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2006. Historical data is provided for the years 2004 and 2005, with forecast data provided for 2007 through 2011. Compound annual growth rates (CAGRs) are provided for the 2004-2006, 2006-2011 and 2004-2011 periods for each industry segment covered. Competitive analysis is provided for the year 2006 with a projected competitive analysis for 2011.

The forecasted market analysis for 2007-2011 is based on probability of approval and sales of products in late stage development, product marketing, and demographic trends.

Table of Contents


Chapter One: Executive Summary

Chapter Two: Introduction The World Anesthesia

Chapter Three: General Anesthesia

Chapter Four: Local Anesthesia

Chapter Five: Adjunctive Therapies in Anesthesia

Chapter Six: Anesthesia Drugs: Total Market Size and Forecast

Chapter Seven: Issues and Trends

Chapter Eight: Corporate Profiles

Appendix: Anesthesia List of Companies

 

table of exhibits

 

Chapter One: Executive Summary

Chapter Two: Introduction: The World Anesthesia  Drug Market

Chapter Three: General Anesthesia

Chapter Four: Local Anesthesia

Chapter Five: Adjunctive Therapies in Anesthesia

Chapter Six: Anesthesia Drugs: Total Market Size and Forecast

 

Other users found this report page using the following search terms: Anesthesia surgery pain market anaesthesia anesthesia drugs anesthetic worldwide general local anesthetics drug

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.